# Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion

> **NCT07141303** · PHASE3 · RECRUITING · sponsor: **Tang-Du Hospital** · enrollment: 1060 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** The methylprednisolone sodium succinate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07141303
- **Lead sponsor:** Tang-Du Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-08
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 1060 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07141303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07141303, "Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07141303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*